Abbott Laboratories (ABT) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
State of Incorp. IL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,1559,53210,1709,9079,2908,158
Cash and cash equivalents7,8359,1619,8829,5948,9377,675
Short-term investments320371288313353483
Receivables6,1726,0206,2186,4087,1997,179
Inventory, net of allowances, customer advances and progress billings6,8716,6736,1735,7345,8995,691
Inventory6,8716,6736,1735,7345,8995,691
Other undisclosed current assets2,3072,1522,6632,7962,5682,401
Total current assets:23,50524,37725,22424,84524,95623,429
Noncurrent Assets
Operating lease, right-of-use asset   1,116   
Property, plant and equipment9,4499,2829,1628,6898,8188,908
Long-term investments and receivables799776766764734763
Long-term investments799776766764734763
Intangible assets, net (including goodwill)33,09232,93333,25333,13434,33635,404
Goodwill23,25822,92722,79922,28422,74423,179
Intangible assets, net (excluding goodwill)9,83410,00610,45410,85011,59212,225
Regulated entity, other noncurrent assets   71   
Other undisclosed noncurrent assets6,5096,4264,8465,3695,3585,503
Total noncurrent assets:49,84949,41749,21447,95649,24650,578
TOTAL ASSETS:73,35473,79474,43872,80174,20274,007
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,06612,24513,23814,88814,88114,952
Interest and dividends payable820824824
Taxes payable394355338
Employee-related liabilities1,4261,3151,147
Accounts payable4,2114,1674,6074,1334,4934,757
Accrued liabilities7,8558,0788,6318,1157,8947,886
Debt2,2842,2852,2511,11754
Other undisclosed current liabilities    (2,640)(2,494)(2,309)
Total current liabilities:14,35014,53015,48913,36512,39212,647
Noncurrent Liabilities
Long-term debt and lease obligation14,56214,61514,52215,29716,75517,086
Long-term debt, excluding current maturities14,56214,61514,52215,29716,75517,086
Liabilities, other than long-term debt   6,531   
Liability, pension and other postretirement and postemployment benefits   1,784   
Other liabilities   3,804   
Operating lease, liability   943   
Other undisclosed noncurrent liabilities7,0387,4179918,2558,3398,645
Total noncurrent liabilities:21,60022,03222,04423,55225,09425,731
Total liabilities:35,95036,56237,53336,91737,48638,378
Equity
Equity, attributable to parent37,17437,01036,68635,67536,49035,399
Common stock24,61224,48824,70924,56024,42924,304
Treasury stock, value(15,722)(15,307)(15,229)(14,555)(13,720)(13,726)
Accumulated other comprehensive loss(8,071)(8,039)(8,051)(9,445)(8,706)(8,474)
Retained earnings36,35535,86835,25735,11534,48733,295
Equity, attributable to noncontrolling interest230222219209226230
Total equity:37,40437,23236,90535,88436,71635,629
TOTAL LIABILITIES AND EQUITY:73,35473,79474,43872,80174,20274,007

Income Statement (P&L) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues9,9789,74710,09110,41011,25711,895
Cost of revenue(4,483)(4,331)(4,593)(4,629)(4,933)(5,499)
Cost of goods and services sold(4,483)(4,331)(4,593)(4,629)(4,933)(4,987)
Gross profit:5,4955,4165,4985,7816,3246,396
Operating expenses(3,953)(3,907)(4,194)(4,011)(3,948)(3,484)
Operating income:1,5421,5091,3041,7702,3762,912
Nonoperating income25320617012910895
Investment income, nonoperating9810188552614
Other nonoperating income17611168938278
Interest and debt expense(159)(153)(154)(141)(132)(131)
Income from continuing operations before income taxes:1,6361,5621,3201,7582,3522,876
Income tax expense(261)(244)(287)(323)(334)(429)
Income from continuing operations:1,3751,3181,0331,4352,0182,447
Income before gain (loss) on sale of properties:1,4352,0182,447
Net income attributable to parent:1,3751,3181,0331,4352,0182,447
Other undisclosed net loss available to common stockholders, basic(5)(5)(4)(6)(9)(9)
Net income available to common stockholders, diluted:1,3701,3131,0291,4292,0092,438

Comprehensive Income ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income:1,3751,3181,0331,4352,0182,447
Other comprehensive income (loss)(7)58(209)(61)(73)2
Comprehensive income:1,3681,3768241,3741,9452,449
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(25)(46)1,603(678)(159)(102)
Comprehensive income, net of tax, attributable to parent:1,3431,3302,4276961,7862,347

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: